Vlado Perkovic's Publications

• SAT-041 A META-ANALYSIS OF THE REPRESENTATIVENESS OF RANDOMIZED CONTROLLED TRIAL COHORTS IN END-STAGE KIDNEY DISEASE

  Journal articles

  2019

  Kidney International Reports

• Abstract 259 Cardiovascular and Renal Outcomes with Canagliflozin in People with Type 2 Diabetes According to Baseline use of Metformin

  Journal articles

  2019

  Endocrine Practice

• SAT-287 eGFR SLOPE AND THE SUBSEQUENT RISK OF CLINICAL OUTCOMES IN TYPE 2 DIABETES

  Journal articles

  2019

  Kidney International Reports

• SAT-298 EFFECT OF SGLT2 INHIBITORS ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEYDISEASE

  Journal articles

  2019

  Kidney International Reports

• EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE OUTCOMES WITH AND WITHOUT PRESERVED EJECTION FRACTION IN TYPE 2 DIABETES: RESULTS FROM THE CANVAS PROGRAM

  Journal articles

  2019

  Journal of the American College of Cardiology

• Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

  Journal articles

  2018

  The Lancet Diabetes and Endocrinology

• Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop

  Journal articles

  2018

  Kidney International

• Associations between body mass index and the risk of renal events in patients with type 2 diabetes

  Journal articles

  2018

  Nutrition and Diabetes

• Effects of the DPP-4 Inhibitor Linagliptin on Heart Failure Outcomes in Patients With Type 2 Diabetes and Cardio-Renal Disease in CARMELINA

  Conference Papers

  2018

  CIRCULATION

• Reducing cardiovascular risk in people with diabetes and kidney disease

  Journal articles

  2018

  Medical Journal of Australia

• Glucose lowering and the kidney: are all drug classes equal?

  Journal articles

  2018

  The Lancet Diabetes and Endocrinology

• Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease

  Conference Papers

  2018

  DIABETOLOGIA

• New clinical trial designs for establishing drug efficacy and safety in a precision medicine era

  Journal articles

  2018

  Diabetes, Obesity and Metabolism

• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

  Journal articles

  2018

  Cochrane Database of Systematic Reviews

• RELATIVE CONTRIBUTIONS TO MAJOR DIALYSIS RANDOMISED CONTROLLED TRIALS FROM TEN GLOBAL REGIONS

  Conference Abstracts

  2018

  NEPHROLOGY

• FACTORS ASSOCIATED WITH REGRESSION OF LEFT VENTRICULAR MASS INDEX IN THE ACTIVE DIALYSIS TRIAL

  Conference Abstracts

  2018

  NEPHROLOGY

• IMPACT OF EXTENDED HOURS DIALYSIS ON UTILITY-BASED QUALITY OF LIFE: RESULTS FROM THE ACTIVE DIALYSIS TRIAL

  Conference Abstracts

  2018

  NEPHROLOGY

• THE QUALITY OF LIFE IMPROVEMENTS ASSOCIATED WITH EXTENDED HOURS DIALYSIS ARE CONSISTENT ACROSS SUBGROUPS

  Conference Abstracts

  2018

  NEPHROLOGY

• Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

  Journal articles

  2018

  The Lancet Diabetes and Endocrinology

• Letter by Matthews et al Regarding Article, Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist

  Journal articles

  2018

  Circulation

• Baseline characteristics and enrichment results from the SONAR trial

  Journal articles

  2018

  Diabetes, Obesity and Metabolism

• Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease

  Journal articles

  2018

  DIABETES

• Acute Increase in Creatinine after Starting ACE Inhibitor and Vascular Events and Premature Death in Patients with Type 2 Diabetes-The ADVANCE Trial

  Conference Papers

  2018

  DIABETES

• Trial design innovations to accelerate therapeutic advances in chronic kidney disease: Moving from single trials to an ongoing platform

  Journal articles

  2018

  Clinical Journal of the American Society of Nephrology

• Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes A systematic review

  Journal articles

  2018

  Diabetes Research and Clinical Practice

• Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy

  Journal articles

  2018

  Diabetes, Obesity and Metabolism